Bioextrax AB (publ)

Stockholm Stock Exchange BIOEX.ST

Bioextrax AB (publ) EBITDA Margin for the year ending December 31, 2023: -1,004.18%

Bioextrax AB (publ) EBITDA Margin is -1,004.18% for the year ending December 31, 2023, a 78.19% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.
  • Bioextrax AB (publ) EBITDA Margin for the year ending December 31, 2022 was -4,605.06%, a -24.76% change year over year.
  • Bioextrax AB (publ) EBITDA Margin for the year ending December 31, 2021 was -3,691.25%, a 85.10% change year over year.
  • Bioextrax AB (publ) EBITDA Margin for the year ending December 31, 2020 was -24,781.43%.
Key data
Date EBITDA Margin EBIT Margin Depreciation and Amortization EBIT
Market news
SV Wall Street
Stockholm Stock Exchange: BIOEX.ST

Bioextrax AB (publ)

CEO Mr. Edvard Hall
IPO Date April 28, 2020
Location Sweden
Headquarters Skiffervägen 76
Employees 13
Sector Health Care
Industries
Biotechnology Oil Extraction Paper & Forest Products
Description

Bioextrax AB (publ) develops and commercializes a bio-based extraction platform technology. It harvests bioplastics (PHA) granules, organic hydrolyzed protein, keratin fibers, bio-oils, protein-rich by products, and amino acids from bacteria. The company was incorporated in 2014 and is based in Lund, Sweden.

StockViz Staff

February 6, 2025

Any question? Send us an email